AXSM vs LNC · rev $409.6M vs P/E 4.9, rev $9.85B
Axsome Therapeutics Inc (AXSM) versus Lincoln National Corporation (LNC) — a side-by-side from cached financials, not a winner call.
Axsome Therapeutics Inc (AXSM) is a biotechnology company listed on US.
Lincoln National Corporation (LNC) is a insurance - life company listed on US.
Latest reported AXSM revenue for 2026-06-30 was $409.6M. Net income was -$115.9M. AXSM currently screens at market cap $11.96B.
Latest reported LNC revenue for 2026-06-30 was $9.85B. Net income was $1.16B. Revenue was up 85.6% from 2026-03-31 to 2026-06-30. LNC currently screens at market cap $5.94B and trailing P/E 4.9.
AXSM currently screens at market cap $11.96B. LNC currently screens at market cap $5.94B and trailing P/E 4.9.
Not investment advice. Open the AXSM and LNC stock pages for the full models.
Not investment advice.